These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16475197)

  • 1. Proteomics: clinical applications for head and neck squamous cell carcinoma.
    Yarbrough WG; Slebos RJ; Liebler D
    Head Neck; 2006 Jun; 28(6):549-58. PubMed ID: 16475197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.
    Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW
    J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum diagnosis of head and neck squamous cell carcinoma using surface-enhanced desorption ionization mass spectrometry and artificial neural network analyses].
    Cao SM; Guo X; Chen FJ; Yang AK; Chen WK; Li NW
    Ai Zheng; 2007 Jul; 26(7):767-70. PubMed ID: 17626756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving 'omics' technologies for diagnostics of head and neck cancer.
    Nagaraj NS
    Brief Funct Genomic Proteomic; 2009 Jan; 8(1):49-59. PubMed ID: 19273537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer.
    Roesch-Ely M; Nees M; Karsai S; Ruess A; Bogumil R; Warnken U; Schnölzer M; Dietz A; Plinkert PK; Hofele C; Bosch FX
    Oncogene; 2007 Jan; 26(1):54-64. PubMed ID: 16819514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of metalloproteins in the clinical management of head and neck squamous cell carcinoma.
    Scurry WC; Stack BC
    Head Neck; 2007 Dec; 29(12):1144-55. PubMed ID: 17657798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
    Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
    Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen differential proteins in lung adenocarcinoma and lung squamous carcinoma].
    Tian YX; Yang SY; Nan YD; Zhang W; Zhou B; Bu LN; Huo SF; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):145-8. PubMed ID: 18361807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic identification of serum biomarkers for head and neck cancer surveillance.
    Gourin CG; Zhi W; Adam BL
    Laryngoscope; 2009 Jul; 119(7):1291-302. PubMed ID: 19444892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
    Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
    Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cell proteomic approach for the detection of secretable biomarkers of invasiveness in oral squamous cell carcinoma.
    Mlynarek AM; Balys RL; Su J; Hier MP; Black MJ; Alaoui-Jamali MA
    Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):910-8. PubMed ID: 17875858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers.
    Ralhan R; Masui O; Desouza LV; Matta A; Macha M; Siu KW
    Proteomics; 2011 Jun; 11(12):2363-76. PubMed ID: 21598386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum protein profile analysis following definitive treatment in patients with head and neck squamous cell carcinoma.
    Gourin CG; Moretz WH; Weinberger PM; Xia ZS; Liu Z; Terris DJ; Adam BL
    Arch Otolaryngol Head Neck Surg; 2007 Nov; 133(11):1125-30. PubMed ID: 18025317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma.
    Ohshiro K; Rosenthal DI; Koomen JM; Streckfus CF; Chambers M; Kobayashi R; El-Naggar AK
    Int J Oncol; 2007 Mar; 30(3):743-9. PubMed ID: 17273777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proteomics and breast cancer].
    Mathelin C; Tomasetto C; Cromer A; Rio MC
    Gynecol Obstet Fertil; 2006 Dec; 34(12):1161-9. PubMed ID: 17123853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncoproteomics: current trends and future perspectives.
    Cho WC; Cheng CH
    Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving in-depth proteomics profiling by mass spectrometry.
    Ahn NG; Shabb JB; Old WM; Resing KA
    ACS Chem Biol; 2007 Jan; 2(1):39-52. PubMed ID: 17243782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics for the identification of new prostate cancer biomarkers.
    Ornstein DK; Tyson DR
    Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum protein profile analysis in patients with head and neck squamous cell carcinoma.
    Gourin CG; Xia ZS; Han Y; French AM; O'Rourke AK; Terris DJ; Adam BL
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):390-7. PubMed ID: 16618908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
    El-Aneed A; Banoub J
    Anticancer Res; 2006; 26(5A):3293-300. PubMed ID: 17094443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.